跳至主要内容
临床试验/JPRN-jRCT2080222176
JPRN-jRCT2080222176未知2 期

A Phase II, Repeated-dose clinical pharmacology Study, Evaluating the Pharmacokinetics and Safety of KRP-AB1102F DPI in Patients With Mild to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Kyorin Pharmaceutical Co.,LTD0 个研究点目标入组 10 人开始时间: 2013年8月20日最近更新:
适应症

试验速览

阶段
2 期
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 40age old 至 ot applicable(—)
性别
Male

入选标准

  • COPD patients with post-bronchodilator FEV1 between 30 % and more of predicted

排除标准

  • - Patient hospitalized for an acute COPD exacerbation within 3 months prior to hospitalization day for this study
  • - Current active tuberculopsis, and others

研究者

相似试验

进行中(未招募)
不适用
A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency - RDEA594 Renal Impairment in Patients with Hyperuricemia and Gout
EUCTR2009-014762-26-BEArdea Biosciences, Inc.24
进行中(未招募)
1 期
Phase II study with pharmacokinetic and pharmacodynamic evaluations of metronomic chemotherapy with oral Vinorelbine and Dexamethasone in advanced castraction-resistant prostate cancer patients - ProMet-3
EUCTR2009-015116-17-ITARCO
进行中(未招募)
1 期
Phase II study to assess the safety and efficacy of LNPP1955 in patients with psoriasisModerate to severe plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000018190
EUCTR2016-001531-12-HUupin Limited40
进行中(未招募)
1 期
A Phase II, Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.Moderate to Severe Rheumatoid Arthritis.MedDRA version: 19.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-001532-35-HUupin Limited64
进行中(未招募)
1 期
A Phase II, Clinical Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of LNP1955 in Patients with Moderate to Severe Rheumatoid Arthritis.Moderate to Severe Rheumatoid Arthritis.MedDRA version: 20.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-001532-35-BGupin Limited64